MTM Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
MTM Financial Group's IBB Position: Q2 2026 in Review
MTM Financial Group reduced its iShares Biotechnology ETF (IBB) stake by 3.2% in Q2 2026, selling an estimated $10.5K and leaving 1,857 shares worth $353K. The position accounts for 0.15% of the portfolio, ranked #68.
MTM Financial Group first reported a position in IBB in Q1 2022 and has held it in 18 quarters since. The position peaked at $448K in Q1 2022. 953 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- MTM Financial Group held 1,857 shares of iShares Biotechnology ETF worth $353K as of Q2 2026.
- MTM Financial Group sold 61 iShares Biotechnology ETF shares in Q2 2026, an estimated $10.5K.
- iShares Biotechnology ETF made up 0.15% of MTM Financial Group's portfolio in Q2 2026, its #68 holding.
- MTM Financial Group first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 18 quarters since.
- MTM Financial Group's iShares Biotechnology ETF position peaked at $448K in Q1 2022.
- 953 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on MTM Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.